Table 1 Characteristics of 60 patients in the septic group
From: Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study
Septic group (n = 60) | ||
|---|---|---|
Demographic data | ||
Age, years | 70 (64-76) | |
Male sex | 46 (76.7%) | |
ASA status: I; II; III; IV; V | 1 (1.7%); 11 (18.3%); 29 (48.3%); 15 (25.0%); 1 (1.7%) | |
Primary site of infection (double-naming feasible) | ||
Lung | 12 (20.0%) | |
Gastrointestinal tract | 32 (53.3%) | |
Genitourinary tract | 6 (10.0%) | |
Others | 18 (30.0%) | |
Unknown | 4 (6.7%) | |
Infection type | ||
Gram-positive isolates | 16 (26.7%) | |
Gram-negative isolates | 16 (26.7%) | |
Combination of both | 18 (30.0%) | |
Suspected infection without any microbiological finding | 10 (16.7%) | |
Septic organ failures | ||
Septic shock | 60 (100.0%) | |
Acute renal failure | 35 (58.3%) | |
Acute respiratory distress syndrome | 49 (81.2%) | |
Acute liver failure | 15 (25.0%) | |
Disease severity scoring | S/T0 | S/T1 |
APACHE II score | 33 (27-38) | 33 (28-39) |
SAPS | 75 (66-86) | 73 (64-84) |
SOFA score | 14 (11-15) | 14 (12-15) |
Clinical data | S/T0 | S/T1 |
Norepinephrine, μg/kg per minute | 0.20 (0.06-0.31) | 0.20 (0.08-0.32) |
Maximum heart rate, 1/minute | 115 (97-130) | 113 (102-127) |
Minimum MAP, mm Hg | 57 (50-64) | 60 (54-66) |
FiO2, none | 0.65 (0.50-0.80) | 0.58 (0.46-0.70) |